Search
Bemarituzumab
go.drugbank.com/drugs/DB16105InvestigationalBemarituzumab is under investigation in clinical trial NCT03694522 (A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (Mfolfox6) in Gastric/gastroesophageal Junction Cancer (FIGHT)).
Hypoxanthine
go.drugbank.com/drugs/DB04076InvestigationalHypoxanthine is a purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
Tarextumab
go.drugbank.com/drugs/DB12104InvestigationalTarextumab has been used in trials studying the treatment of Solid Tumors, Stage IV Pancreatic Cancer, and Stage IV Small Cell Lung Cancer.
2-Hydroxyestradiol
go.drugbank.com/drugs/DB07706Experimental2-Hydroxyestradiol is classified as an endogenous steroid, catechol estrogen, and metabolite of estradiol. It is also a positional isomer of estriol. [A31630]
Avotaciclib
go.drugbank.com/drugs/DB16652InvestigationalAvotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).
Fuzapladib
go.drugbank.com/drugs/DB19478ExperimentalFuzapladib is a small molecule drug. The usage of the INN stem '-pladib' in the name indicates that Fuzapladib is a phospholipase A2 inhibitor.
Umibecestat
go.drugbank.com/drugs/DB19898ExperimentalUmibecestat is a small molecule drug. The usage of the INN stem '-becestat' in the name indicates that Umibecestat is a beta secretase inhibitor.
Tomicorat
go.drugbank.com/drugs/DB20822ExperimentalTomicorat is a small molecule drug. The usage of the INN stem '-corat' in the name indicates that Tomicorat is a glucocorticoid receptor agonist.
Zaloglanstat
go.drugbank.com/drugs/DB21495ExperimentalZaloglanstat is a small molecule drug. The usage of the INN stem '-glanstat' in the name indicates that Zaloglanstat is a prostaglandin synthase inhibitor.
Zevaquenabant
go.drugbank.com/drugs/DB21590ExperimentalZevaquenabant is a small molecule drug. The usage of the INN stem '-nabant' in the name indicates that Zevaquenabant is a cannabinoid receptor antagonist.